O'Connor John James 4
Research Summary
AI-generated summary
LEMAITRE VASCULAR (LMAT) Director John O'Connor Receives Award
What Happened
- Director John O'Connor was credited with five dividend-equivalent awards on 2026-06-04, totaling 4.071 dividend-equivalent rights (0.466 + 0.558 + 0.76 + 0.86 + 1.427). Each was reported as an acquisition (code A) at $0.00 — these are derivative, non-cash accruals tied to existing restricted stock unit (RSU) and performance share unit (PSU) awards. The filing reports $0 cash value for these entries because they are dividend equivalents that vest proportionately with the underlying awards.
Key Details
- Transaction date: 2026-06-04; Form 4 filed: 2026-06-05 (timely).
- Reported entries: 0.466, 0.558, 0.76, 0.86, and 1.427 dividend-equivalent rights; price per unit reported $0.00.
- Shares owned after transaction: not specified in the provided filing excerpt.
- Footnotes: each amount represents dividend-equivalent rights that accrued on prior awards and vest proportionately:
- F1: accrued on RSU grant dated 12/8/2023
- F2: accrued on PSU grant dated 12/8/2023
- F3: accrued on RSU grant dated 12/6/2024
- F4: accrued on PSU grant dated 12/6/2024
- F5: accrued on RSU grant dated 12/10/2025
- Transaction code: A = Award/Grant (derivative accruals), not a cash purchase or sale.
Context
- Dividend-equivalent rights are bookkeeping credits that mirror dividends on underlying RSUs/PSUs and generally vest according to the schedule of the original awards; they are not immediate open-market purchases or sales. Such accruals are routine compensation mechanics and do not necessarily indicate a personal buy/sell decision by the insider.